MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

MDT

88.42

-0.26%↓

VEEV

282.22

-0.26%↓

120.83

+0.49%↑

WBA

11.48

-0.09%↓

HQY

101.21

-1.67%↓

Inicio・Lista de Acciones・Lisata Therapeutics

L
Lisata Therapeutics

Cerrado

2.7 -3.91

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.66

Máximo

2.77

Métricas clave
By Trading Economics
Empleados	26

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+424.48% upside

Dividendos
By Dow Jones
Próximas Ganancias	11 ago 2025

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	2.3M 22M
Apertura anterior	6.61
Cierre anterior	2.7

Lisata Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

2 jul 2025, 17:03 UTC

Principales Movimientos del Mercado

Furniture Companies Rise on U.S. Trade Deal With Vietnam

2 jul 2025, 15:18 UTC

Principales Movimientos del Mercado

Mogo Shares Rally After Embrace of Bitcoin Into Holdings, Operations

2 jul 2025, 23:45 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

2 jul 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

2 jul 2025, 23:40 UTC

Charlas de Mercado

Gold Edges Lower Amid Hopes for More Trade Deals -- Market Talk

2 jul 2025, 21:01 UTC

Adquisiciones, fusiones, absorciones

AT&T Completes Sale of Entire Remaining 70% Stake in DIRECTV to TPG >T

2 jul 2025, 21:01 UTC

Adquisiciones, fusiones, absorciones

AT&T and TPG Close DIRECTV Transaction

2 jul 2025, 20:26 UTC

Ganancias

Rivian Stock Drops on Sales Decline. The Stakes Are High for the Rest of 2025. -- Barrons.com

2 jul 2025, 20:22 UTC

Charlas de Mercado

Gold Rises Following Weak ADP Payroll Reading -- Market Talk

2 jul 2025, 20:13 UTC

Charlas de Mercado

Oil Price Expectations Stable in Dallas Fed Survey -- Market Talk

2 jul 2025, 19:09 UTC

Charlas de Mercado

Oil Futures Bounce in Defiance of Downbeat Data -- Market Talk

2 jul 2025, 19:08 UTC

Charlas de Mercado

Dollar Trims Gains as Investors Brace for Cooling Jobs Market -- Market Talk

2 jul 2025, 19:01 UTC

Charlas de Mercado

U.S. Natural Gas Ticks Up Ahead of Storage Data -- Market Talk

2 jul 2025, 18:08 UTC

Charlas de Mercado

Fossil Fuels Rule Energy Roost As U.S. Marks Independence -- Market Talk

2 jul 2025, 17:06 UTC

Adquisiciones, fusiones, absorciones

BCE: Maple Leafs, Raptors Rights Access Through Long-Term Agreement With Rogers, Subject to League Approvals

2 jul 2025, 17:05 UTC

Adquisiciones, fusiones, absorciones

BCE: Access to Content Rights for Toronto Maple Leafs, Toronto Raptors on TSN Secured Through 2043/2044 Season

2 jul 2025, 17:04 UTC

Adquisiciones, fusiones, absorciones

BCE: Proceeds of MLSE Stake Sale to Support Financing of Acquisition of Ziply Fiber

2 jul 2025, 17:04 UTC

Adquisiciones, fusiones, absorciones

BCE Inc. Concludes Sale of Minority Stake in Maple Leaf Sports & Entertainment

2 jul 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Rogers Communications: Now Largest Owner With 75% Interest in Maple Leaf Sports & Entertainment

2 jul 2025, 17:02 UTC

Adquisiciones, fusiones, absorciones

Rogers Communications Closes Deal to Buy BCE's 37.5% Stake in Maple Leaf Sports & Entertainment for C$4.7B

2 jul 2025, 16:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

2 jul 2025, 16:20 UTC

Charlas de Mercado

Cushing Crude Stock Slide Keeps Bid in WTI -- Market Talk

2 jul 2025, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

2 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

2 jul 2025, 16:11 UTC

Charlas de Mercado

Copper Prices Hold Higher on Supply Disruption, Tariff Uncertainty -- Market Talk

2 jul 2025, 16:09 UTC

Charlas de Mercado

Gold Futures Rise, Recouping Some Losses -- Market Talk

2 jul 2025, 15:59 UTC

Ganancias

These Stocks Are Moving the Most Today: Tesla, Centene, Apple, Adobe, Rigetti Computing, Greenbrier, and More -- Barrons.com

2 jul 2025, 15:17 UTC

Charlas de Mercado

Oil Market to Keep Close Watch on U.S. Payrolls -- Market Talk

2 jul 2025, 15:08 UTC

Charlas de Mercado

Luxury Sector Should Report a Slowdown -- Market Talk

2 jul 2025, 15:00 UTC

Adquisiciones, fusiones, absorciones

Glencore: Merger of Viterra With Bunge Global Closed

Comparación entre iguales

Cambio de precio

Lisata Therapeutics Esperado

Precio Objetivo

By TipRanks

424.48% repunte

Estimación a 12 meses

Media 15 USD 424.48%

Máximo 15 USD

Mínimo 15 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Lisata Therapeutics Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

Comprar

Mantener

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Lisata Therapeutics Dist en los últimos 3 meses.

Finanzas

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.